X0609 4 2026-04-23 0 0001764013 Immunovant, Inc. IMVT 0001618670 Girao Tiago false C/O IMMUNOVANT, INC. 1000 PARK FORTY PLAZA, SUITE 210 DURHAM NC 27713 0 1 0 0 Chief Financial Officer 0 Common Stock 2026-04-23 4 S 0 25760 29.62 D 247596 D On May 1, 2025, the holder was granted 208,388 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on May 5, 2025, of which 52,097 of these RSUs vested on April 21, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. /s/ Tiago Girao 2026-04-24